Research output per year
Research output per year
Personal profile
Research interests
DR VIJ is Associate Professor at Washington University School of Medicine in the Division of Medical Oncology, Section of Bone Marrow Transplantation and Leukemia. Dr Vij’s primary academic interests include the treatment of hematologic malignancies and hematopoietic stem cell transplantation. He is involved in several collaborations with other members of the Siteman Cancer Center in studying the biology of plasma cell dyscrasias. He serves on numerous committees including the Core Transplant Committee of the CALGB, Project Review Committee of the Multiple Myeloma Research Consortium and on the Guidelines Committee for the National Comprehensive Cancer Network (NCCN). He is an author on numerous publications in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation and numerous book chapters. He has served as a reviewer for prestigious journals including Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Experimental Hematology, and Haematologica and for the American Society of Hematology.
Clinical interests
Stem cell transplant, multiple myeloma, myelodysplastic syndrome, hematologic malignancy, leukemia, lymphoma
Fingerprint
Dive into the research topics where Ravi Vij is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Case of Paucisymptomatic Unilateral Isolated Optic Disc Edema from Bing–Neel Syndrome
Yamada, M. M., Gore, S., Vij, R., Van Stavern, G. P. & Stunkel, L., 2025, In: Neuro-Ophthalmology. 49, 4, p. 327-330 4 p.Research output: Contribution to journal › Article › peer-review
-
Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States
Hultcrantz, M., Kleinman, D., Vij, R., Escalante, F., Delforge, M., Kotowsky, N., Bitetti, J., Boytsov, N., Camadoo-O’Byrne, L., Happ, L. P., Germain, G., Urosevic, A., Mahendran, M., Duh, M. S., Laliberté, F., Cavo, M. & Lee, H. C., Mar 2025, In: Haematologica. 110, 3, p. 753-757 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
Slade, M. J., Fortier, J., Khaled, A., Fiala, M., McDonald, Z., Zaydman, M. A., Wan, F., Schroeder, M. A., Stockerl-Goldstein, K., Yang, L. & Vij, R., Sep 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 9, p. e628-e637.e4Research output: Contribution to journal › Article › peer-review
-
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS
Hossain, N. M., Ahn, K. W., Patel, J., Lian, Q., Bilal Abid, M., Al Nughmush, A., Bacher, U., Bi, X., Hashmi, S. K., Hilal, T., Husnain, M., Khimani, F., Maziarz, R. T., Modi, D., Ram, R., Rizzieri, D., Sica, R. A., Steinberg, A., Vij, R. & Shadman, M. & 3 others, , Sep 2025, In: British Journal of Haematology. 207, 3, p. 1011-1018 8 p.Research output: Contribution to journal › Article › peer-review
-
Correction to: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes (Nature Genetics, (2024), 56, 9, (1878-1889), 10.1038/s41588-024-01853-0)
The MMRF CoMMpass Network, Jul 2025, In: Nature Genetics. 57, 7, p. 1789 1 p.Research output: Contribution to journal › Comment/debate
Open Access